Role of maternal pertussis antibodies in infants

Annelies Van Rie1, Aaron M Wendelboe, Janet A Englund

  • 1Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA. vanrie@unc.edu

Insights

Pertussis poses a significant threat to infants before vaccination. Maternal antibodies offer limited protection, highlighting the need for enhanced infant immunity through maternal or neonatal pertussis vaccination strategies.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Pertussis (whooping cough) is a severe disease in infants, with most fatalities occurring before 3 months of age, prior to initial vaccination.
  • Maternal antibodies transferred to infants provide short-lived protection, but protective levels are difficult to ascertain due to a lack of serologic correlates.
  • Current vaccination schedules leave young infants vulnerable during their first months of life.

Purpose of the Study:

  • To investigate strategies for enhancing protection in young infants against pertussis.
  • To explore the potential of maternal or neonatal vaccination to bolster infant immunity against pertussis.

Main Methods:

  • Review of historical and recent studies on maternal and neonatal pertussis immunization.
  • Analysis of evidence from animal and human studies regarding the immunogenicity of acellular pertussis vaccines in neonates.

Main Results:

  • Historical attempts at maternal pertussis immunization in pregnancy yielded limited published data.
  • Recent research indicates that neonatal immunization with acellular pertussis vaccine can effectively prime T and B cells.
  • This neonatal priming may form a foundation for robust future immune responses against pertussis.

Conclusions:

  • Limited but promising data suggest maternal and neonatal pertussis immunization could protect vulnerable infants.
  • Further research is crucial to establish effective vaccination protocols to reduce infant pertussis mortality and morbidity.
  • Optimizing infant protection against pertussis requires exploring novel immunization approaches beyond traditional infant vaccination schedules.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...